The Water-Blueberry Study
Study Details
Study Description
Brief Summary
We will study the effect of supplementation of 1 L blueberry juice to participants with at least one elevated cardiovasculat risk factor.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1/Phase 2 |
Detailed Description
Participants with at leat one elevated cardiovacsular risk factor, as defined as systolic blood pressure between 140 and 165 mmHg, diastolic blood pressure between 90 and 105 mmHg, low density lipoprotein (LDL) cholesterol ≥3.4 mmol/L, total/high density lipoprotein (HDL) cholesterol ratio >4 or smoking a minimum of 3 cigarettes daily.
Subjects were randomized to two groups, where the blueberry group were supplemented with 1 L blueberry juice per day for four weeks. The control group consumed an equal amount of water.
Clinical markers, as well as biomarkers of antioxidant status, oxidative stress status and inflammation were measured in blood samples before amd after the intervention period.
Study Design
Outcome Measures
Primary Outcome Measures
- Primary endpoints are cardiovascular risk factors [4 weeks]
Secondary Outcome Measures
- Secondary endpoints are additional clinical markers, as well as biomarkers of antioxidant status, oxidative stress status and inflammation [4 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
30-70 years for men and 45-70 years or at least 12 months postmenopausal for women
-
at least one elevated cardiovascular risk factor, defined as systolic blood pressure between 140 and 165 mmHg, diastolic blood pressure between 90 and 105 mmHg, low density lipoprotein (LDL) cholesterol ≥3.4 mmol/L, total/high density lipoprotein (HDL) cholesterol ratio >4 or smoking a minimum of 3 cigarettes daily.
Exclusion Criteria:
-
clinically recognized chronic diseases as impaired renal function, diabetes mellitus, cardiovascular disease, liver or gastrointestinal disease or cancer within the last 5 years
-
use of lipid-lowering drugs, diuretics or hormone replacement therapy for women
-
Subjects with a body-mass index ≥31
-
with a alcohol consumption above 3 units/day for men and 1 unit/day for women
-
blood donation within the last six months
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Oslo
- Ullevaal University Hospital
Investigators
- Principal Investigator: Rune Blomhoff, PhD, University of Oslo
- Principal Investigator: Serena Tonstad, MD, Ullevaal University Hospital
- Principal Investigator: Anette Karlsen, MSc, University of Oslo
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Water-Blueberry Study
- REK SØR ref nr 39-03-01166